Table 2 Cycle characteristics of the two study groups
Characteristics | RE group (n = 95) | Matched group (n = 190) | P-value |
|---|---|---|---|
Fresh ET cycle, n(%) | 50(52.6%) | 100(52.6%) | |
Frozen ET cycle, n(%) | 45(47.4%) | 90(47.4%) | |
Stimulation protocol, n(%) | |||
Long agonist | 44(88.0%) | 88(88.0%) | |
Antagonist | 6(12.0%) | 12(12.0%) | |
Total dose of Gn (IU) | 3049.4 ± 1408.2 | 2850.6 ± 897.5 | 0.280 |
Endometrium thickness (mm) | 11.1 ± 3.2 | 10.8 ± 2.4 | 0.645 |
No. of oocytes retrieved | 10.3 ± 6.1 | 11.3 ± 5.4 | 0.195 |
No. of good quality embryos | 4.9 ± 3.2 | 4.8 ± 2.8 | 0.918 |
Protocol for frozen ET, n(%) | |||
Natural cycle | 10(28.6%) | 20(28.6%) | |
Artificial cycle | 35(77.8%) | 70(77.8%) | |
Cleavage-stage ET, n(%) | 69(72.6%) | 138(72.6%) | |
Blastocyst transfer, n(%) | 26(27.4%) | 52(27.4%) | |